Hello, Fool! | Login | Signup | My Fool
Nov 22, 2008 6:41 PM ET | Feedback | Site Changes | Help
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
View All Commentary (BMRN)
Recs
snazzysnazz (< 20) Submitted: 1/18/07 12:34 PM : Start Price: $17.45 BMRN Score: 30.46
Great pipeline and future outlook on their own. Also a great buy-out opportunity for one of the big boys. All in all, this stock will double in the next year or so with or without a buy-out. Hang on to this one!!!
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK